TOR signaling is a determinant of cell survival in response to DNA damage

Changxian Shen1, Cynthia S Lancaster, Bin Shi

  • 1Department of Molecular Pharmacology, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA.

Insights

Target of rapamycin (TOR) kinase regulates cell survival during genotoxic stress. Inhibiting TORC1 signaling in yeast enhances lethality from DNA damage by blocking DNA repair, impacting cancer drug resistance.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Genetics

Background:

  • The conserved target of rapamycin (TOR) kinase pathway, particularly TORC1, is crucial for cellular responses to environmental stressors like starvation and hypoxia.
  • Dysregulation of Akt-TOR signaling is implicated in cancer development, making this pathway a target for chemotherapeutics.

Purpose of the Study:

  • To investigate the role of rapamycin-sensitive TORC1 signaling in yeast cell survival and S-phase progression under genotoxic stress.
  • To elucidate the mechanism by which TORC1 influences DNA damage response and mutagenesis.

Main Methods:

  • Utilized yeast models exposed to the DNA-damaging agent methyl methanesulfonate (MMS).
  • Assessed the impact of rapamycin inhibition on TORC1 signaling, S-phase checkpoint activation (Rad53), and ribonucleotide reductase (Rnr1, Rnr3) expression.
  • Examined cell viability and mutagenesis rates in wild-type and RNR3-deleted yeast strains.

Main Results:

  • Rapamycin-sensitive TORC1 signaling is essential for yeast cell viability and S-phase progression following genotoxic stress.
  • TORC1 inhibition suppressed Rad53-mediated induction of Rnr1 and Rnr3, reducing MMS-induced mutagenesis but increasing cell lethality.
  • Deletion of RNR3 conferred hypersensitivity to combined rapamycin and MMS treatment, highlighting Rnr3's role in DNA damage survival.

Conclusions:

  • TORC1 functions as a survival pathway during genotoxic stress by maintaining deoxynucleoside triphosphate pools for DNA repair polymerases.
  • TOR-dependent survival under DNA-damaging conditions correlates with increased mutation rates, potentially contributing to chemotherapeutic resistance.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...